Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Accounts Payables: 2021-2025

Historic Accounts Payables for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $12.2 million.

  • LifeStance Health's Accounts Payables rose 6774.24% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year increase of 6774.24%. This contributed to the annual value of $7.2 million for FY2024, which is 270.88% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Accounts Payables is $12.2 million, which was up 6774.24% from $7.8 million recorded in Q2 2025.
  • LifeStance Health's Accounts Payables' 5-year high stood at $15.1 million during Q1 2022, with a 5-year trough of $3.1 million in Q3 2021.
  • For the 5-year period, LifeStance Health's Accounts Payables averaged around $9.6 million, with its median value being $9.0 million (2021).
  • As far as peak fluctuations go, LifeStance Health's Accounts Payables soared by 15852.31% in 2022, and later tumbled by 4906.84% in 2023.
  • LifeStance Health's Accounts Payables (Quarter) stood at $14.2 million in 2021, then dropped by 13.19% to $12.3 million in 2022, then tumbled by 42.6% to $7.1 million in 2023, then increased by 2.71% to $7.2 million in 2024, then skyrocketed by 68.67% to $12.2 million in 2025.
  • Its last three reported values are $12.2 million in Q3 2025, $7.8 million for Q2 2025, and $7.4 million during Q1 2025.